{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "epsTrailingTwelveMonths": -0.34, "sharesOutstanding": 57000000, "bookValue": 9.026, "fiftyDayAverage": 181.38, "fiftyDayAverageChange": -2.380005, "fiftyDayAverageChangePercent": -0.01312165, "twoHundredDayAverage": 121.4605, "twoHundredDayAverageChange": 57.539497, "twoHundredDayAverageChangePercent": 0.47373012, "marketCap": 10635338752, "priceToBook": 19.831598, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "currency": "TWD", "financialCurrency": "TWD", "regularMarketOpen": 178.0, "averageDailyVolume3Month": 194993, "averageDailyVolume10Day": 64428, "fiftyTwoWeekLowChange": 134.95, "fiftyTwoWeekLowChangePercent": 3.063564, "fiftyTwoWeekRange": "44.05 - 221.0", "fiftyTwoWeekHighChange": -42.0, "fiftyTwoWeekHighChangePercent": -0.19004525, "fiftyTwoWeekLow": 44.05, "fiftyTwoWeekHigh": 221.0, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "firstTradeDateMilliseconds": 1601859600000, "priceHint": 2, "marketState": "POSTPOST", "regularMarketChange": 0.5, "regularMarketTime": 1684131346, "regularMarketDayHigh": 179.5, "regularMarketDayRange": "176.5 - 179.5", "regularMarketDayLow": 176.5, "regularMarketVolume": 14324, "regularMarketPreviousClose": 178.5, "bid": 177.0, "ask": 179.0, "fullExchangeName": "Taipei Exchange", "regularMarketChangePercent": 0.28011206, "regularMarketPrice": 179.0, "exchangeTimezoneName": "Asia/Taipei", "exchangeTimezoneShortName": "CST", "gmtOffSetMilliseconds": 28800000, "esgPopulated": false, "exchange": "TWO", "shortName": "Alar", "longName": "Alar Pharmaceuticals Inc.", "messageBoardId": "finmb_668399108", "market": "tw_market", "symbol": "6785.TWO"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "No. 19, Keyuan Road", "address2": "Rm. 312, 3rd Floor Xitun District", "city": "Taichung", "zip": "407", "country": "Taiwan", "phone": "886 4 2463 7115", "fax": "886 4 2256 9658", "website": "https://www.alarpharm.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Alar Pharmaceuticals Inc. operates as a drug development company. It focuses on developing long-acting release drug products for CNS disorders and chronic diseases, which primarily include opioid use disorder, chronic pain, and major depressive disorder. The company is developing ALA-1000, which is in Phase II clinical trials for the treatment of opioid addiction; and ALA-1300 and ALA-2000, which is in pre-clinical stage for opioid use disorder; and ALA-3000, which is in pre-clinical stage for treating treatment-resistant depression. The company was founded in 2016 and is based in Taichung, Taiwan.", "fullTimeEmployees": 21, "companyOfficers": [{"maxAge": 1, "name": "Dr. Yung-Shun  Wen Ph.D.", "title": "CEO & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Vivian  Kang", "title": "Director of Fin.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}